Codes / ICD10CM / T43.92XA

T43.92XA Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
  • ICD-10 Code: T43.92XA

Summary

This code describes intentional self-harm poisoning by an unspecified psychotropic drug during the initial encounter. Psychotropic drugs affect mental processes and are used to treat conditions like depression, anxiety, or psychosis. The term "unspecified" indicates the specific drug type is not documented, while "intentional self-harm" denotes the event was deliberate, and "initial encounter" refers to the first episode of care for this condition.

Causes

Intentional self-harm poisoning may result from deliberate ingestion of a psychotropic drug with the intent to cause harm. This can occur due to overdose, misuse, or intentional exposure to a substance. The specific drug type is not documented, but the event is confirmed as self-directed.

Risk Factors

  • History of mental health conditions (e.g., depression, anxiety, or psychosis).
  • Prior episodes of self-harm or suicidal behavior.
  • Access to psychotropic medications without supervision.
  • Social or environmental stressors contributing to intentional harm.

Symptoms

Symptoms depend on the drug type but may include:

  • Altered mental status, confusion, or sedation.
  • Nausea, vomiting, or gastrointestinal distress.
  • Changes in heart rate, blood pressure, or respiratory function.
  • Seizures, loss of consciousness, or respiratory depression.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history, and confirmation of intentional self-harm. Toxicology screening may be performed to identify the drug, though the code applies when the specific psychotropic drug is unspecified. Documentation of the self-harm intent and initial encounter is critical.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying intent. This may include decontamination, supportive care, and psychiatric evaluation. Specific interventions depend on the drug's effects and the patient's condition.

Prognosis and Follow-Up

Prognosis varies based on the severity of poisoning and timely intervention. Follow-up care often includes psychiatric assessment, therapy, and safety planning to prevent recurrence. Ongoing monitoring of mental health and medication use is essential.

Complications

Complications can include organ damage (e.g., liver or kidney), respiratory failure, seizures, or long-term psychological effects. Severe cases may result in permanent disability or death.

Lifestyle & Prevention

Prevention involves secure storage of medications, access to mental health support, and education on safe medication use. Encouraging open communication about mental health and reducing stigma around seeking help can lower risk.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., altered mental status, difficulty breathing) occur. Prompt care is critical to minimize harm and address underlying issues.

Tips for Medical Coders

Use this code for initial encounters of intentional self-harm poisoning by an unspecified psychotropic drug. Ensure documentation confirms the self-harm intent and that the drug type is not specified. Do not use this code if the drug is identified or the encounter is not the initial one.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T43.92XA policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.